Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending September 23, 2003. The report primarily details corporate governance activities, specifically changes in directors' interests and a share buyback transaction, rather than providing comprehensive financial results for a fiscal period.
Key Financial Metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. The only specific financial data disclosed relates to a share repurchase transaction:
- Shares Purchased: 795,000 Ordinary 25 pence shares.
- Purchase Date: September 22, 2003.
- Price per Share: 1,252.63 pence.
- Purpose: Cancellation of shares.
Material Changes
The filing reports the following material changes regarding equity and director interests:
- Share Buyback: The company executed a buyback of 795,000 shares under authority granted at the Annual General Meeting on May 19, 2003.
- Director Interests (GSK Trust): On September 19, 2003, the GlaxoSmithKline Employee Trust transferred 6,556 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. Directors Dr. J-P Garnier and Mr. J D Coombe hold interests in this trust as potential beneficiaries.
- Director Interests (Employee Benefit Trust): On September 19, 2003, the SmithKline Beecham Employee Benefit Trust transferred 17,503 Ordinary Shares to participants in the SmithKline Beecham Bonus Investment Plan. Directors Dr. J P Garnier and John Coombe hold interests in this fund as potential beneficiaries.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risks, contingencies, or unusual items. The document is strictly a notification of regulatory compliance regarding share transactions and director holdings.
Investor Verification Checklist
- Verify the total number of shares remaining in the buyback authority following the September 22 transaction.
- Confirm the aggregate cost of the 795,000 shares purchased at 1,252.63 pence per share.
- Review the full Annual Report (Form 20-F) for the fiscal year to obtain revenue, profit, and cash flow data not present in this 6-K.
- Check subsequent filings for further updates on the Employee Trusts and Bonus Investment Plan distributions.